Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More


Texas Medical Center

Gastroenterology, Hepatology and Nutrition
Phone: 832-822-3131
Fax: 832-825-4131


6701 Fannin Street
Suite 1100
Houston, TX 77030

Faith Ihekweazu, MD, MS

Assistant Professor of Pediatrics, Baylor College of Medicine


School Education Degree Year
Baylor College of Medicine Masters Master of Clinical Investigation 2017
Baylor College of Medicine Fellowship Pediatric Gastroenterology 2016
New York Presbyterian Hospital - Columbia Medical Center Internship/Residency Pediatrics 2012
Baylor College of Medicine Medical School Doctor of Medicine 2009


Clinical Interests:

Dr. Ihekweazu’s clinical interests include general pediatric gastroenterology, with a primary focus on Inflammatory Bowel Diseases.

Research Interests:

Dr. Ihekweazu’s research focuses on the relationship between the gut microbiome and Inflammatory bowel diseases (IBD), including Ulcerative Colitis and Crohn’s disease.  Her ultimate goal is to better understand the disease process and provide more effective treatment options for patients with IBD, by targeting the microbiome.  She is also involved in the Intestinal Microbiome Transplantation (IMT) program.


Organization Name Role
American Gastroenterological Association
Houston Medical Forum Member
North American Society of Pediatric Gastroenterology, Hepatology and Nutrition

Selected Publications

Ihekweazu FD, Ajjarapu A, Kellermayer R.  Diagnostic Yield of Routine Enteropathogenic Stool Tests in Pediatric Ulcerative Colitis.  Annals of Clinical and Laboratory Science 2015 Nov;45(6):639-42. PubMed PMID: 26663793.

Ihekweazu FD¸Kellermayer R. (2015) Fecal Microbiota Transplantation: is it time for children?  In M. Manfredi & G.L. de’Angelis (Eds.), Probiotics in Children (pp 309-326) New York, NY: Nova Science Publishers, Inc.  

Ihekweazu FD, Kellermayer R.  Allopurinol: a Useful Adjunct to Thiopurine Therapy for Pediatric Ulcerative Colitis in the Biologic Era.  Journal of Pediatric Gastroenterology and Nutrition 2014 Jul; 59(1):22-4.  PubMed PMID:  24590210

Ihekweazu FD, Nagy-Szakal D, Fishman DS, Kellermayer R.  Hyperlipasemia in Pediatric Inflammatory Bowel Diseases.  Pancreas 2016 Feb;45(2):e2-3. PubMed PMID: 26752257

Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018 Nov; 365(5):413-423. PubMed PMID: 30384950.

Ihekweazu FD, Fofanova TY, Queliza K, Nagy-Szakal D, Stewart CJ, Engevik MA, Hulten KG, Tatevian N, Graham DY, Versalovic J, Petrosino JF, Kellermayer R. Bacteroides ovatus ATCC 8483 Monotherapy is Superior to Traditional Fecal Transplant and Multi-strain Bacteriotherapy in a Murine Colitis Model. Gut Microbes 2019 Jan 21:1-17. PubMed PMID: 30663928.

View PubMed Publications

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.